SOTERA HEALTH COMPANY Diluted Shares Outstanding (Weighted Average)
SOTERA HEALTH COMPANY (SHC) reported Diluted Shares Outstanding (Weighted Average) of 288.15 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 288.15M shares, a 0.84% increase year-over-year.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 287.62M shares, a 1.43% increase year-over-year.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 287.63M shares, a 0.69% increase year-over-year.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 286.75M shares, a 0.41% increase year-over-year.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, diluted for fiscal 2025 was 286.42M shares, a 0.53% increase from fiscal 2024.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, diluted for fiscal 2024 was 284.91M shares, a 0.59% increase from fiscal 2023.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, diluted for fiscal 2023 was 283.22M shares, a 1.12% increase from fiscal 2022.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, diluted for fiscal 2022 was 280.10M shares, a 0.26% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 288.15M shares 10-Q · filed 2026-08-06 | 287.92M shares 10-Q · filed 2026-08-06 | 287.80M shares derived: average of 3 quarters · filed 2026-08-06 | 287.54M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 287.62M shares 10-Q · filed 2026-05-05 | 287.62M shares derived: average of 2 quarters · filed 2026-05-05 | 287.33M shares derived: average of 3 quarters · filed 2026-05-05 | 286.94M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 287.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 287.19M shares derived: average of 2 quarters · filed 2026-02-24 | 286.71M shares derived: average of 3 quarters · filed 2026-08-06 | 286.42M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 286.75M shares 10-Q · filed 2025-11-04 | 286.25M shares derived: average of 2 quarters · filed 2026-08-06 | 286.02M shares 10-Q · filed 2025-11-04 | 285.43M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 285.76M shares 10-Q · filed 2026-08-06 | 283.75M shares 10-Q · filed 2026-08-06 | 284.99M shares derived: average of 3 quarters · filed 2026-08-06 | 285.13M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 283.56M shares 10-Q · filed 2026-05-05 | 284.60M shares derived: average of 2 quarters · filed 2026-05-05 | 284.92M shares derived: average of 3 quarters · filed 2026-05-05 | 284.83M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 285.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 285.60M shares derived: average of 2 quarters · filed 2026-02-24 | 285.25M shares derived: average of 3 quarters · filed 2026-02-24 | 284.91M shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 285.56M shares 10-Q · filed 2025-11-04 | 285.05M shares derived: average of 2 quarters · filed 2025-11-04 | 284.66M shares 10-Q · filed 2025-11-04 | 284.37M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 284.54M shares 10-Q · filed 2025-08-08 | 284.26M shares 10-Q · filed 2025-08-08 | 283.97M shares derived: average of 3 quarters · filed 2026-02-24 | 283.26M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 284.06M shares 10-Q · filed 2025-05-01 | 283.69M shares derived: average of 2 quarters · filed 2026-02-24 | 282.83M shares derived: average of 3 quarters · filed 2026-02-24 | 282.91M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 283.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 282.21M shares derived: average of 2 quarters · filed 2026-02-24 | 282.52M shares derived: average of 3 quarters · filed 2026-02-24 | 283.22M shares 10-K · filed 2026-02-24 |
| 2023-09-30 | 281.11M shares 10-Q · filed 2024-11-05 | 282.13M shares derived: average of 2 quarters · filed 2024-11-05 | 283.19M shares 10-Q · filed 2024-11-05 | 281.83M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 283.15M shares 10-Q · filed 2024-08-05 | 283.04M shares 10-Q · filed 2024-08-05 | 282.08M shares derived: average of 3 quarters · filed 2025-02-27 | 281.60M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 282.98M shares 10-Q · filed 2024-05-02 | 281.54M shares derived: average of 2 quarters · filed 2025-02-27 | 281.08M shares derived: average of 3 quarters · filed 2025-02-27 | 280.86M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 280.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 280.14M shares derived: average of 2 quarters · filed 2025-02-27 | 280.15M shares derived: average of 3 quarters · filed 2025-02-27 | 280.10M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 280.17M shares 10-Q · filed 2023-11-01 | 280.17M shares derived: average of 2 quarters · filed 2023-11-01 | 280.09M shares 10-Q · filed 2023-11-01 | 280.00M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 280.17M shares 10-Q · filed 2023-08-03 | 280.04M shares 10-Q · filed 2023-08-03 | 279.95M shares derived: average of 3 quarters · filed 2024-02-27 | 279.85M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 279.91M shares 10-Q · filed 2023-05-03 | 279.84M shares derived: average of 2 quarters · filed 2024-02-27 | 279.75M shares derived: average of 3 quarters · filed 2024-02-27 | 279.61M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 279.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 279.66M shares derived: average of 2 quarters · filed 2024-02-27 | 279.51M shares derived: average of 3 quarters · filed 2024-02-27 | 279.38M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 279.56M shares 10-Q · filed 2022-11-02 | 279.39M shares derived: average of 2 quarters · filed 2022-11-02 | 279.25M shares 10-Q · filed 2022-11-02 | 272.83M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | 279.21M shares 10-Q · filed 2022-08-04 | 279.08M shares 10-Q · filed 2022-08-04 | 270.59M shares derived: average of 3 quarters · filed 2023-02-28 | 261.04M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | 278.97M shares 10-Q · filed 2022-05-05 | 266.28M shares derived: average of 2 quarters · filed 2023-02-28 | 254.98M shares derived: average of 3 quarters · filed 2023-02-28 | 249.34M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | 253.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 242.99M shares derived: average of 2 quarters · filed 2023-02-28 | 239.46M shares derived: average of 3 quarters · filed 2023-02-28 | 237.70M shares 10-K · filed 2023-02-28 |
| 2020-09-30 | 232.40M shares 10-Q · filed 2021-11-10 | 232.40M shares derived: average of 2 quarters · filed 2021-11-10 | 232.40M shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 232.40M shares 10-Q · filed 2021-08-12 | 232.40M shares 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 232.40M shares 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | 232.40M shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |